Esperion Therapeutics | ESPR

Stock Price
7.78
Daily Change
1.17%
Yearly
-71.21%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Daiichi Sankyo 2,965.00 -70.00 -2.31% -23.70%
AbbVie 116.51 -2.15 -1.81% 11.08%
Adamas Pharmaceuticals 8.22 0.06 0.74% 91.16%
Alnylam Pharmaceuticals 188.53 -0.27 -0.14% 45.18%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 201.09 -2.88 -1.41% -10.55%
Amarin 3.64 -0.21 -5.45% -20.87%
Arena Pharmaceuticals 57.42 -1.54 -2.61% -12.87%
Biogen 242.90 -7.23 -2.89% -0.36%
BioMarin Pharmaceutical 87.58 -1.99 -2.22% 8.93%
Cytokinetics 39.03 -1.87 -4.57% 127.58%
Esperion Therapeutics 7.78 0.09 1.17% -71.21%
Flexion Therapeutics 9.12 -0.02 -0.22% -17.76%
Geron 1.47 -0.07 -4.55% -21.39%
Halozyme Therapeutics 33.85 -1.42 -4.03% -15.86%
Heron Therapeutics 9.41 -0.36 -3.68% -47.69%
Intercept Pharmaceuticals 17.10 -0.65 -3.66% -54.12%
Ionis Pharmaceuticals 29.05 -0.71 -2.39% -42.18%
Intra Cellular Therapies 42.45 -1.11 -2.55% 69.94%
Eli Lilly 260.37 -1.63 -0.62% 76.59%
Merck & Co 79.16 -3.12 -3.79% -0.88%
Moderna Inc 329.63 56.24 20.57% 159.49%
Minerva Neurosciences 1.06 0 0% -73.57%
Nektar Therapeutics 11.21 -0.41 -3.53% -33.23%
Puma Biotechnology 3.23 -0.26 -7.33% -72.51%
Pfizer 54.00 3.11 6.11% 45.04%
PTC Therapeutics 38.06 -1.35 -3.43% -40.52%
Regeneron Pharmaceuticals 643.35 -4.83 -0.75% 25.15%
Sanofi 85.01 -1.64 -1.89% -0.23%
Seattle Genetics 169.50 -3.70 -2.14% 0.22%
Sarepta Therapeutics 79.62 -1.36 -1.68% -42.78%
United Therapeutics 193.64 -6.54 -3.27% 42.87%
Vanda Pharmaceuticals 16.55 -0.78 -4.50% 33.36%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%
Zogenix 11.70 -0.59 -4.80% -45.73%

Indexes Price Day Year
NASDAQ 15492 -353.57 -2.23% 26.92%
US2000 2246 -85.52 -3.67% 21.06%

Esperion Therapeutics
Esperion Therapeutics, Inc. is a lipid management company. The Company is a pharmaceutical company focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). Its bempedoic acid and the bempedoic acid / ezetimibe combination tablets are oral, once-daily, non-statin, LDL-C lowering medicines for patients with atherosclerotic cardiovascular disease (ASCVD), or heterozygous familial hypercholesterolemia (HeFH). Its products include NEXLETOL, NILEMDO, NEXLIZET and NUSTENDI. NEXLETOL and NILEMDO are ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C by reducing cholesterol biosynthesis and up-regulating the LDL receptors. NEXLIZET and NUSTENDI contains bempedoic acid and ezetimibe and lowers elevated LDL-C through complementary mechanisms of action by inhibiting cholesterol synthesis in the liver and absorption in the intestine.